Sumitomo Pharma Co., Ltd.'s Net Worth
$0
Estimate Recalculated Nov 1, 2024 06:31AM EST
Who is Sumitomo Pharma Co., Ltd.?
Sumitomo Pharma Co., Ltd. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Myovant Sciences Ltd., Roivant Sciences Ltd., and Urovant Sciences Ltd..
SEC CIK
Sumitomo Pharma Co., Ltd.'s CIK is 0001446601
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Myovant Sciences Ltd. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 51.6M |
$27.00 | $1,393,178,400.00 | 45.8M |
Mar 10
| |||
Form 4
| -8.48% | -4.24M |
—
|
—
| 45.8M |
Mar 3
| |||
Form 4
| +0.04% | 20.68K |
$22.85 | $472,382.61 | 50.04M |
Scheduled
|
Sep 28
| ||
Form 4
| +0.17% | 84K |
$23.87 | $2,004,937.44 | 50.02M |
Scheduled
|
Sep 24 - Sep 27
| ||
Form 4
| +0.28% | 138.8K |
$22.39 | $3,108,225.66 | 49.94M |
Scheduled
|
Sep 22 - Sep 23
| ||
Form 4
| +0.16% | 81.27K |
$22.30 | $1,812,119.53 | 49.8M |
Scheduled
|
Sep 20 - Sep 21
| ||
Form 4
| +0.18% | 87.91K |
$22.20 | $1,951,655.51 | 49.72M |
Scheduled
|
Sep 16 - Sep 17
| ||
Form 4
| +0.33% | 161.16K |
$22.03 | $3,551,175.01 | 49.63M |
Scheduled
|
Sep 14 - Sep 15
| ||
Form 4
| +0.23% | 113.18K |
$23.84 | $2,698,438.60 | 49.47M |
Scheduled
|
Sep 10 - Sep 13
| ||
Form 4
| +0.12% | 58.9K |
$25.60 | $1,507,810.80 | 49.35M |
Scheduled
|
Sep 8 - Sep 9
| ||
Form 4
| +0.13% | 64.4K |
$26.49 | $1,705,922.61 | 49.3M |
Scheduled
|
Sep 3 - Sep 7
| ||
Form 4
| +0.21% | 103.1K |
$25.60 | $2,638,920.66 | 49.23M |
Scheduled
|
Sep 1 - Sep 2
| ||
Form 4
| +0.22% | 109K |
$24.05 | $2,620,983.90 | 49.13M |
Scheduled
|
Aug 30 - Aug 31
| ||
Form 4
| +0.16% | 77.04K |
$22.91 | $1,765,163.94 | 49.02M |
Scheduled
|
Aug 26 - Aug 27
| ||
Form 4
| +0.13% | 63.01K |
$22.40 | $1,411,426.82 | 48.94M |
Scheduled
|
Aug 24 - Aug 25
| ||
Form 4
| +0.21% | 101.92K |
$21.65 | $2,206,276.42 | 48.88M |
Scheduled
|
Aug 20 - Aug 23
| ||
Form 4
| +0.13% | 63.91K |
$21.49 | $1,373,513.04 | 48.78M |
Scheduled
|
Aug 18 - Aug 19
| ||
Form 4
| +0.15% | 71.72K |
$21.21 | $1,521,194.21 | 48.71M |
Scheduled
|
Aug 16 - Aug 17
| ||
Form 4
| +0.18% | 87.9K |
$12.31 | $1,081,911.74 | 48.64M |
Scheduled
|
May 19 - May 20
| ||
Form 4
| +0.17% | 84.81K |
$12.22 | $1,036,590.02 | 48.55M |
Scheduled
|
May 15 - May 18
| ||
Form 4
| +0.19% | 91.33K |
$12.18 | $1,112,400.58 | 48.47M |
Scheduled
|
May 13 - May 14
| ||
Form 4
| +0.12% | 59.45K |
$13.08 | $777,788.94 | 48.38M |
Scheduled
|
May 11 - May 12
| ||
Form 4/A
| +0.10% | 50K |
$12.24 | $612,075.00 | 48.25M |
Scheduled
|
May 6
| ||
Form 4
| +0.15% | 70K |
$12.73 | $891,212.00 | 48.32M |
Scheduled
|
May 7 - May 8
| ||
Form 4
| +0.21% | 100K |
$11.97 | $1,196,540.00 | 48.25M |
Scheduled
|
May 5
| ||
Form 4
| +0.21% | 100K |
$11.44 | $1,144,050.00 | 48.15M |
Scheduled
|
May 1 - May 4
| ||
Form 4
| +0.21% | 100K |
$12.00 | $1,199,720.00 | 48.05M |
Scheduled
|
Apr 29 - Apr 30
| ||
Form 4
| +0.19% | 90.5K |
$12.11 | $1,096,022.24 | 47.95M |
Scheduled
|
Apr 27 - Apr 28
| ||
Form 4
| +0.16% | 78.09K |
$12.24 | $955,447.10 | 47.86M |
Scheduled
|
Apr 23 - Apr 24
| ||
Form 4
| +0.21% | 100.2K |
$11.76 | $1,177,870.30 | 47.78M |
Scheduled
|
Apr 21 - Apr 22
| ||
Form 4
| +0.25% | 120.3K |
$11.20 | $1,347,961.28 | 47.68M |
Scheduled
|
Apr 17 - Apr 20
| ||
Form 4
| +0.30% | 140K |
$10.56 | $1,478,372.00 | 47.56M |
Scheduled
|
Apr 15 - Apr 16
| ||
Form 4
| +0.30% | 140K |
$10.40 | $1,456,651.00 | 47.42M |
Scheduled
|
Apr 13 - Apr 14
| ||
Form 4
| +0.15% | 70K |
$9.37 | $655,669.00 | 47.28M |
Scheduled
|
Apr 9
| ||
Form 4
| +0.30% | 140K |
$8.37 | $1,171,303.00 | 47.21M |
Scheduled
|
Apr 7 - Apr 8
| ||
Form 4
| +0.30% | 140K |
$8.18 | $1,145,445.00 | 47.07M |
Scheduled
|
Apr 3 - Apr 6
| ||
Form 4
| +0.30% | 140K |
$7.60 | $1,063,384.00 | 46.93M |
Scheduled
|
Apr 1 - Apr 2
| ||
Form 4
| +0.30% | 140K |
$7.81 | $1,093,750.00 | 46.79M |
Scheduled
|
Mar 30 - Mar 31
| ||
Form 4
| +0.30% | 140K |
$7.96 | $1,114,057.00 | 46.65M |
Scheduled
|
Mar 26 - Mar 27
| ||
Form 4
| +0.69% | 319.3K |
$7.65 | $2,442,453.83 | 46.51M |
Scheduled
|
Mar 24 - Mar 25
| ||
Form 4
| +0.88% | 405.1K |
$7.64 | $3,094,640.80 | 46.19M |
Scheduled
|
Mar 20 - Mar 23
| ||
Form 4
| +0.85% | 387.8K |
$7.54 | $2,923,895.66 | 45.78M |
Scheduled
|
Mar 18 - Mar 19
| ||
Form 4
| +0.86% | 387.8K |
$7.32 | $2,839,956.35 | 45.4M |
Scheduled
|
Mar 16 - Mar 17
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Roivant Sciences Ltd. (ROIV) Snapshot price: $12.4
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -17.50% | -15.12M |
$8.60 | -$129,999,982.20 | 71.25M |
Jun 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Urovant Sciences Ltd. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.45% | 103.25K |
$13.08 | $1,350,510.00 | 22.96M |
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||